Guardant Health Boosts 2025 Revenue Forecast to $880-890M on Robust Oncology and Screening Growth
Insights from the Earnings Call: Guardant Health (GH) First Quarter 2025 Management View …
Read more
Guardant Health Boosts 2025 Revenue Forecast to $880-890M on Robust Oncology and Screening Growth